Tucidinostat: all 160 studies that test it
Page 2 of 2. Open to participants first (73), then studies with results posted, then the rest; newest registration first within each.
- Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.CompletedNCT05068427Phase 2
- A Proof-of-concept Trial to Evaluate the Safety and Efficacy of UB-421 Plus Chidamide in Changing HIV ReservoirsCompletedNCT05056974Phase 2
- Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast CancerStatus unknownNCT05047848Not applicable
- Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLHStatus unknownNCT05008666Phase 2
- Tucidinostat and Fulvestrant in Hormone-receptor Positive Advanced Breast CancerStatus unknownNCT04999540Phase 2
- Chidamide Plus Camrelizumab as Second-line Therapy for Advanced ESCC Treated With PD-1 BlockadeStatus unknownNCT04984018Phase 2
- Sintilimab in Combination With Chidamide in Refractory and Relapsed AITLStatus unknownNCT04831710Phase 2
- Maintenance Therapy of Chidamide in Patients With HBV Positive Diffuse Large B-cell LymphomaCompletedNCT04661943Phase 2
- Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical CancerTerminatedNCT04651127Phase 1/2
- Chidamide With Immunotherapy for Patients With Locally Advanced or Metastatic Urothelial CarcinomaCompletedNCT04562311Phase 2
- Decitabine-primed Tandem CD19/CD20 CAR T Cells Plus Epigenetic Agents in Aggressive r/r B-NHL With Huge Tumor BurdenStatus unknownNCT04553393Phase 1/2
- Radiotherapy Combined With GDP With or Without Chidamide in Stage I/II Extranodal Nasal NK/T-cell LymphomaStatus unknownNCT04511351Not applicable
- A Clinical Trial of Chidamide Combined With Etoposide in Relapsed or Refractory NK/T-cell LymphomaStatus unknownNCT04490590Phase 4
- Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional ChemotherapyStatus unknownNCT04480125Phase 2
- Neoadjuvant Tucidinostat and Exemestane in Early Breast CancerCompletedNCT04465097Phase 2
- Sintilimab Plus Chidamide in the Treatment of Relapsed and Refractory Cutaneous T-cell Lymphoma: a Multicenter Phase II StudyStatus unknownNCT04296786Phase 2
- Phase III Study of Tucidinostat in Combination With R-CHOP in Patients With Newly Diagnosed Double-Expressor DLBCLCompletedNCT04231448Phase 3
- Chidamide Combined With Toripalimab in SarcomaCompletedNCT04025931Phase 2
- Biomarker Guided Treatment in DLBCLStatus unknownNCT04025593Phase 2
- Chidamide + R-GemOx Regimen as Salvage Treatment for Transplant-ineligible Patients With Relapsed/Refractory DLBCLCompletedNCT04022005Phase 2
- Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's LymphomaCompletedNCT03974243Phase 1/2
- Study Evaluating the Safety and Efficacy of C-CHOP in Untreated Subjects With Angioimmunoblastic T Cell LymphomaStatus unknownNCT03853044Phase 2
- A Clinical Trial of Chidamide in the Management of Refractory ITPCompletedNCT03838354Phase 1/2
- Sintilimab in Combination With Chidamide in Refractory and Relapsed ENKTCLCompletedNCT03820596Phase 1/2
- Maintenance Treatment of Chidamide in Stage IV or Relapsed/Refractory Extranodal NK/T-cell LymphomaStatus unknownNCT03630731Phase 2
- Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma SubjectsStatus unknownNCT03629873Phase 2
- Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma PatientsStatus unknownNCT03617432Phase 2
- Chidamide Maintenance After Autologous Hematopoietic Stem Cell Transplantation for Relapsed, Refractory or High-risk LymphomaStatus unknownNCT03611231Phase 2
- Phase 2 Trial of Chidamide-Lenalidomide-Dexamethasone(CRD) Regimen in R/R MMStatus unknownNCT03605056Phase 2
- Chidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin LymphomaStatus unknownNCT03602131Phase 2
- Tofacitinib Combined With Chidamide in R/R ENKTCLStatus unknownNCT03598959Phase 2
- Phase II Umbrella Study Directed by Next Generation SequencingStatus unknownNCT03574402Phase 2
- Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALLStatus unknownNCT03564704Phase 2/3
- Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALLStatus unknownNCT03564470Phase 2/3
- Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALLStatus unknownNCT03553238Phase 2/3
- Chidamide for Patients With Recurrent and Metastatic Epstein-Barr Virus (EBV)-Associated Solid TumorsStatus unknownNCT03494634Phase 2
- Chidamide for Patients With Relapse or Refractory Diffuse Large B-Cell Lymphoma and Follicular LymphomaStatus unknownNCT03410004Phase 2
- Chidamide Plus PTCy/Cyclosporine to Prevent GVHD After Myeloablative Conditioning, Matched PBSCTStatus unknownNCT03336632Phase 2
- Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)Status unknownNCT03321890Phase 2
- Chidamide With PET Regimen for Angioimmunoblastic T Cell Lymphoma (PET: Prednisone, Etoposide and Thalidomide)Status unknownNCT03273452Phase 2
- Chidamide With CHOP Regimen for de Novo PTCL Patients (CHOP: Cyclophosphamide, Etoposide, Vincristine and Prednisone; PTCL: Peripheral T Cell Lymphoma)Status unknownNCT03268889Not applicable
- Study of Chidamide as a Single-agent Treatment for Patients With Relapse or Refractory B-NHLStatus unknownNCT03245905Phase 2
- Chidamide With R-CHOP Regimen for DLBCL PatientsStatus unknownNCT03201471Phase 2
- Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell LymphomaStatus unknownNCT03151876Phase 2
- Efficacy and Safety of Chidamide in CBF LeukemiaActive, not recruitingNCT03031262Phase 1/2
- Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma PatientsStatus unknownNCT03023358Phase 3
- Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell LymphomaStatus unknownNCT02987244Phase 1/2
- Chidamide for Refractory/Relapsed Peripheral T Cell LymphomaStatus unknownNCT02944812Phase 2
- Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and SafetyStatus unknownNCT02883374Phase 2
- Differences Between Chidamide Taken Daily and Twice a Week in Therapeutic Effect，Pharmacokinetics, Pharmacodynamics and EB Virus ActivationStatus unknownNCT02878278Phase 2
- Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell LymphomaStatus unknownNCT02856997Phase 2
- Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma PatientsCompletedNCT02809573Phase 1
- Chidamide Plus R-CHOP in Elderly DLBCLStatus unknownNCT02753647Phase 2
- Chidamide Plus Chemotherapy in the Treatment of Peripheral T-cell LymphomaStatus unknownNCT02753543Phase 2
- Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell LymphomaStatus unknownNCT02733380Phase 2
- Safety Study of HBI-8000 in Japanese Patients With Non Hodgkin's LymphomaCompletedNCT02697552Phase 1
- Dose Escalation Study of HBI-8000 in Combination With Paclitaxel and Trastuzumab in Women With Advanced or Metastatic HER2+ Breast CancerWithdrawnNCT02569489Phase 1
- Chidamide in Combination With Antiretroviral Therapy for Eradication of the Latent HIV-1 ReservoirCompletedNCT02513901Phase 1/2
- Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast CancerCompletedNCT02482753Phase 3
- Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung CancerCompletedNCT01836679Phase 2